No Carolina / NY / Florida
Ph: 561.316.3330

Carestream Shares Path to Accelerated Delivery of AI Features at HPE Discover 2022 Conference

Editor: What To Know

  • Additionally, it frees up our imaging scientists to focus more time on creating solutions for our customers in healthcare and less energy on building the ‘plumbing' needed for AI solution creation,” explained Mr.
  • Carestream had a significant reduction in the time to execute a training run for its AI-based Smart Noise Cancellation from ~60 hours to 16.
  • “Carestream is leveraging AI in our medical imaging solutions to develop new applications that help improve clinical outcomes and patient care, and accelerate workflow,” said Dharmendu Damany, Chief Technology Officer at Carestream.

Carestream Health will share its path and commitment to delivering artificial-intelligence-powered features for medical imaging at the HPE Discover Edge-to-Cloud user conference June 28-30.

Carestream is the featured healthcare company at the conference, delivering a session on “Transforming Healthcare: Carestream Delivers AI with Edge-to-Cloud Platform” and participating in a panel on “Accelerating Your Transformation with the Cloud Experience Everywhere – From Customers Who Have.”

Carestream leverages HPE GreenLake’s enterprise-grade cloud service for machine learning (ML Ops platform) to accelerate development of its AI applications for medical imaging. The platform enables an accelerated workflow for research, including testing AI models on clinical data, getting faster feedback and deploying better solutions.

“Carestream is leveraging AI in our medical imaging solutions to develop new applications that help improve clinical outcomes and patient care, and accelerate workflow,” said Dharmendu Damany, Chief Technology Officer at Carestream. “HPE’s ML Ops platform helps us deliver our innovative solutions to the healthcare market more quickly.”

The HPE platform provides the massive computing power necessary to accelerate Carestream’s development of AI-powered imaging, workflow automation and analytics innovations. Case in point: Carestream had a significant reduction in the time to execute a training run for its AI-based Smart Noise Cancellation from ~60 hours to 16. Smart Noise Cancellation provides improved diagnostic quality, preservation of fine detail and better contrast-to-noise ratio for images acquired at clinically nominal exposures.*

“HPE gives us a platform to successfully manage the expanding scope and scale of our AI activities. Additionally, it frees up our imaging scientists to focus more time on creating solutions for our customers in healthcare and less energy on building the ‘plumbing’ needed for AI solution creation,” explained Mr. Damany.

Carestream’s presentation on “Transforming Healthcare: Carestream Delivers AI with Edge-to-Cloud Platform” will be delivered on Wednesday, June 29 at noon by John Kopcienski, Director, Systems Architecture and Platformed Components, and Mark Hourani, AI & Data Practice Lead at HPE. Mr. Kopcienski will join the panel discussion on “Accelerating Your Transformation with the Cloud Experience Everywhere – From Customers Who Have” on June 29 at 4:30 p.m.

*These statements were verified using Carestream detectors in a reader study performed by board certified radiologists comparing pairwise images taken at nominal dose (CsI ISO 400 speed / GOS ISO 320 speed) and reduced dose (CsI ISO 800 speed / GOS ISO 500 speed) with SNC. This study led to an FDA 510k clearance of SNC for dose reduction.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy